Alnylam Pharmaceuticals
ALNY
#640
Rank
C$44.31 B
Marketcap
$343.60
Share price
-3.51%
Change (1 day)
37.88%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company